RNA Advisors
  • Home
  • Who We Serve
  • What We Do
    • Commercial Operations
    • Strategic Advisory
    • Transactional Support
    • Valuation Advisory
  • Industries
  • About Us
    • Our Team
    • Careers
  • Insights
  • Contact
Select Page
Client Success: Mandatory Adoption of ASC 842 –  Incremental Borrowing Rate Analysis for Private Biotech

Client Success: Mandatory Adoption of ASC 842 – Incremental Borrowing Rate Analysis for Private Biotech

by RNA | Apr 20, 2022 | Client Success, Valuation Advisory

By Jeff Suchocki, CFA The Situation: Adoption of ASC 842 – Lease Accounting is mandatory for all private companies for fiscal years beginning after December 15, 2021. To comply with this mandatory adoption requirement, a privately held, clinical stage biotech company...

Read More

Client Success: Incremental Borrowing Rate Analysis for Publicly Traded, Clinical Stage Biotech

Client Success: Incremental Borrowing Rate Analysis for Publicly Traded, Clinical Stage Biotech

by RNA | Jul 25, 2019 | Client Success, Strategic Advisory, Valuation Advisory

THE PROBLEM:  A publicly traded clinical stage biotech company needed to understand the correct implied discount rate for a lease agreement in accordance with ASC 842 rules. THE SOLUTION: ASC 842 has specific rules relating to leases, including guidance on lease...

Read More

Client Succes: Derivatives Valuation for pre-IPO Biotechnology Company

Client Succes: Derivatives Valuation for pre-IPO Biotechnology Company

by RNA | Oct 20, 2016 | Client Success, Valuation Advisory

THE PROBLEM: A development stage biotechnology company (considering an IPO in the near future) entered into a series of financings which required the valuation of components of the financings deemed to be a derivative for financial reporting purposes. THE SOLUTION:...

Read More

Categories

  • Client Success
  • RNA Team News
  • Strategic Advisory
  • Valuation Advisory

Recent Post

  • Transaction support
    Client Success: Transaction Support to Assess Value from Different Perspectives
  • Interest Rates
    Client Success: Mandatory Adoption of ASC 842 – Incremental Borrowing Rate Analysis for Private Biotech
  • Commercial Operations
    Client Success: Strategic Extension for Revenue-Stage Medtech
  • Home
  • Who We Serve
  • What We Do
  • Industries
  • About Us
  • Insights
  • Contact

Contact

200 S. Virginia St, 8th Floor
Reno, NV 89501
Phone: 833-421-1159
Email: info@rnaadvisors.com

Follow

  • Follow
© 2023 RNA Advisors, LLC. All rights reserved.